In the BioHarmony Drug Report Database
Zidovudine
Retrovir, Zidovudine, Trizivir (zidovudine) is a small molecule pharmaceutical. Zidovudine was first approved as Retrovir on 1987-03-19. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections.
Trade Name
|
Trizivir |
|---|---|
Common Name
|
zidovudine |
ChEMBL ID
|
CHEMBL129 |
Indication
|
acquired immunodeficiency syndrome, hiv infections |
Drug Class
|
Antineoplastics,antivirals (zidovudine group) (exception: edoxudine) |
Image (chem structure or protein)